Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity
Clinical trial NCT02751931 · COMPLETED
Trial details
- NCT number
- NCT02751931
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-17
- Primary completion
- 2018-11-05
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.